Namandje Bumpus

RXRX

Namandje Bumpus serves as director at Recursion Pharmaceuticals, Inc. (RXRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$15.5K

Net Position

Net Seller

$15.5K

Companies Traded

RXRX

Active Period

Jun 2026

1 total trades

Most Recent

Sell RXRX

Jun 4, 2026 · $15.5K

Namandje Bumpus's Insider Trading at Recursion Pharmaceuticals, Inc. (RXRX)

Buys

0 · $0.00

Sells

1 · $15.5K

Total Shares Bought

Total Shares Sold

4,386

RXRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 4, 2026	Sell	4,386	$3.54	$15.5K	43,171

Related Insiders

Christopher Gibson

Director

RXRXSell · Jun 5, 2026

Najat Khan

director, officer: CEO and President

RXRXSell · Jun 5, 2026

Blake Borgeson

Director

RXRXSell · Jun 4, 2026

Ben R Taylor

officer: Chief Financial Officer

RXRXSell · Mar 18, 2026

David Hallett

Chief Scientific Officer

RXRXSell · Feb 17, 2026

Explore More Insider Trading Data

RXRX Insider Trading Activity

View all insider trades at Recursion Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity